Search

everythinglearnresearchcommunity

for

Search:↓

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Insulin therapy helped a man with autoimmune issues regrow his hair.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Leflunomide is more likely to help treat alopecia areata than cause it.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Vitamin D is crucial for health, and deficiency can cause hair loss and other health issues.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.